Evidence map›Paper›PMID 42768044›Full record

ArticleNature communications2026

Differential lipid selectivity of StARD phospholipid transporters revealed by native MS.

Carla Kirschbaum, Sophie A S Lawrence, Jack L Bennett, Olivia B Ramsay, Yara Ahmed, Tarick J El-Baba, Stefano Vanni, Carol V Robinson

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carla KirschbaumKavli Institute for Nanoscience Discovery, University of Oxford, Oxford, UK. carla.kirschbaum@charite.de.ORCID http://orcid.org/0000-0003-3192-0785
Sophie A S LawrenceKavli Institute for Nanoscience Discovery, University of Oxford, Oxford, UK.ORCID http://orcid.org/0009-0005-6652-4792
Jack L BennettKavli Institute for Nanoscience Discovery, University of Oxford, Oxford, UK.
Olivia B RamsayKavli Institute for Nanoscience Discovery, University of Oxford, Oxford, UK.ORCID http://orcid.org/0009-0009-7284-2278
Yara AhmedDepartment of Biology, University of Fribourg, Fribourg, Switzerland.ORCID http://orcid.org/0009-0007-6141-1742
Tarick J El-BabaKavli Institute for Nanoscience Discovery, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4497-9938
Stefano VanniDepartment of Biology, University of Fribourg, Fribourg, Switzerland.ORCID http://orcid.org/0000-0003-2146-1140
Carol V RobinsonKavli Institute for Nanoscience Discovery, University of Oxford, Oxford, UK. carol.robinson@chem.ox.ac.uk.ORCID http://orcid.org/0000-0001-7829-5505

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 803952Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) CR00I5-236020Wellcome TrustWellcome Trust (Wellcome) 221795/Z/20/Z
6 · The paper itself

Abstract

Intracellular lipid transport in eukaryotes is largely mediated by lipid transfer proteins (LTPs). Transport kinetics differ markedly among lipid species, implying selective lipid recognition by the involved proteins. Here, we characterize endogenous ligands of the human phospholipid transporters STARD2, STARD7, and STARD10 by multistage native mass spectrometry (MS). Our results demonstrate that they exhibit distinct lipid selectivities, with STARD7 binding a broad range of phospholipids, whereas STARD2 and STARD10 preferentially copurify with poly- and di-unsaturated phospholipids, respectively. We link this acyl chain selectivity to tissue-specific LTP expression patterns and show that LTP expression levels modulate lipid metabolism. Through site-directed mutagenesis and molecular dynamics simulations, we further identify a conserved arginine that is essential for phospholipid binding in STARD7 but dispensable in STARD2 and STARD10. To investigate regulation of LTP activity, we mapped phosphorylation sites by native top-down MS and found that STARD2 and STARD10 are phosphorylated in membrane-binding regions. Liposome-based assays revealed that phosphorylation abolishes lipid transfer activity of STARD10 and that lipid selectivity influences the transfer rates of different lipid probes. Together, our results demonstrate that LTPs exhibit distinct lipid binding preferences and suggest that cells finely tune lipid homeostasis by regulating LTP expression levels and activity.

Indexed as

Carrier ProteinsPhospholipidsPhospholipid Transfer ProteinsBinding SitesBiological TransportHEK293 CellsHumansLipid MetabolismMass SpectrometryMolecular Dynamics SimulationMutagenesis, Site-DirectedPhosphorylationProtein BindingCarrier ProteinsPhospholipidsPhospholipid Transfer Proteins

Identifiers

PMID42768044
PMCPMC13594186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.